Maplight Therapeutics, Inc. · NASDAQ:MPLT
Foff Erin Pennock sold 15,355 Maplight Therapeutics, Inc. shares (Form 4)
Traded Oct 15, 2026 · Filed Oct 16, 2026
On Oct 15, 2026, Foff Erin Pennock (Chief Medical Officer) sold 15,355 Maplight Therapeutics, Inc. shares at US$8.08 for US$124K, leaving 296,906 shares. Filed Oct 16, 2026 (Form 4).
- Sold
- 15,355 shares
- Price
- US$8.08
- Value
- US$124K
- Holding after
- 296,906 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Voting Common Stock | Sale | 15,355 | US$8.08 | 296,906 | Direct |
Source
Download original · View original at SEC
Related
- Maplight Therapeutics, Inc.
- Foff Erin Pennock
- Maplight Therapeutics, Inc. shareholders
- Form 4 · Foff Erin Pennock · Aug 19, 2026
- Form 4 · Foff Erin Pennock · Jul 17, 2026
- Form 4 · Foff Erin Pennock · May 11, 2026
- Form 4 · Foff Erin Pennock · May 6, 2026
- Form 4 · Foff Erin Pennock · Apr 17, 2026
- Form 4 · Gillis Jonathan · Oct 16, 2026
- Form 4 · Kroeger Christopher A. · Oct 16, 2026
- Form 4 · Hanson Kristopher · Oct 16, 2026
- Form 4 · Kreitzer Anatol · Oct 16, 2026
- Form 4 · Lillie James Woodruff · Oct 16, 2026